Protalix BioTherapeutics
PLX
PLX
63 hedge funds and large institutions have $17.6M invested in Protalix BioTherapeutics in 2025 Q2 according to their latest regulatory filings, with 30 funds opening new positions, 19 increasing their positions, 4 reducing their positions, and 30 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
more funds holding
Funds holding: →
0% more first-time investments, than exits
New positions opened: 30 | Existing positions closed: 30
16% less capital invested
Capital invested by funds: $21M → $17.6M (-$3.33M)
Holders
63
Holding in Top 10
–
Calls
$379K
Puts
$58K
Top Buyers
| 1 | +$4.61M | |
| 2 | +$1.22M | |
| 3 | +$718K | |
| 4 |
State Street
Boston,
Massachusetts
|
+$657K |
| 5 |
Renaissance Technologies
New York
|
+$631K |
Top Sellers
| 1 | -$2.47M | |
| 2 | -$1.57M | |
| 3 | -$829K | |
| 4 |
Jane Street
New York
|
-$753K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$536K |
